AHMED, Niaz, Heinrich AUDEBERT, Guillaume TURC, Charlotte CORDONNIER, Hanne CHRISTENSEN, Simona SACCO, Else Charlotte SANDSET, George NTAIOS, Andreas CHARIDIMOU, Danilo TONI, Christian PRISTIPINO, Martin KOHRMANN, Joji B. KURAMATSU, Geotz THOMALLA, Robert MIKULÍK, Gary A. FORD, Joan MARTI-FABREGAS, Urs FISCHER, Magnus THOREN, Erik LUNDSTROM, Gabriel J. E. RINKEL, H. Bart VAN DER WORP, Marius MATUSEVICIUS, Georgios TSIVGOULIS, Haralampos MILIONIS, Marta RUBIERA, Robert HART, Tiago MOREIRA, Maria LANTZ, Christina SJOSTRAND, Grethe ANDERSEN, Peter SCHELLINGER, Konstantinos KOSTULAS, Katharina Stibrant SUNNERHAGEN, Boris KESELMAN, Eleni KOROMPOKI, Jan PURRUCKER, Pooja KHATRI, William WHITELEY, Eivind BERGE, Michael MAZYA, Diederik W. J. DIPPEL, Satu MUSTANOJA, Mads RASMUSSEN, Asa Kuntze SODERQVIST, Irene ESCUDERO-MARTINEZ and Thorsten STEINER. Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018. EUROPEAN STROKE JOURNAL. LONDON: SAGE PUBLICATIONS LTD, 2019, vol. 4, No 4, p. 307-317. ISSN 2396-9873. Available from: https://dx.doi.org/10.1177/2396987319863606.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018
Authors AHMED, Niaz (752 Sweden, guarantor), Heinrich AUDEBERT (276 Germany), Guillaume TURC (250 France), Charlotte CORDONNIER (250 France), Hanne CHRISTENSEN (208 Denmark), Simona SACCO (380 Italy), Else Charlotte SANDSET (578 Norway), George NTAIOS (300 Greece), Andreas CHARIDIMOU (840 United States of America), Danilo TONI (380 Italy), Christian PRISTIPINO (380 Italy), Martin KOHRMANN (276 Germany), Joji B. KURAMATSU (276 Germany), Geotz THOMALLA (276 Germany), Robert MIKULÍK (203 Czech Republic, belonging to the institution), Gary A. FORD (826 United Kingdom of Great Britain and Northern Ireland), Joan MARTI-FABREGAS (724 Spain), Urs FISCHER (756 Switzerland), Magnus THOREN (752 Sweden), Erik LUNDSTROM (752 Sweden), Gabriel J. E. RINKEL (528 Netherlands), H. Bart VAN DER WORP (528 Netherlands), Marius MATUSEVICIUS (752 Sweden), Georgios TSIVGOULIS (300 Greece), Haralampos MILIONIS (300 Greece), Marta RUBIERA (724 Spain), Robert HART (124 Canada), Tiago MOREIRA (752 Sweden), Maria LANTZ (752 Sweden), Christina SJOSTRAND (752 Sweden), Grethe ANDERSEN (208 Denmark), Peter SCHELLINGER (276 Germany), Konstantinos KOSTULAS (752 Sweden), Katharina Stibrant SUNNERHAGEN (300 Greece), Boris KESELMAN (752 Sweden), Eleni KOROMPOKI (300 Greece), Jan PURRUCKER (276 Germany), Pooja KHATRI (840 United States of America), William WHITELEY (826 United Kingdom of Great Britain and Northern Ireland), Eivind BERGE (578 Norway), Michael MAZYA (752 Sweden), Diederik W. J. DIPPEL (528 Netherlands), Satu MUSTANOJA (246 Finland), Mads RASMUSSEN (208 Denmark), Asa Kuntze SODERQVIST (752 Sweden), Irene ESCUDERO-MARTINEZ (724 Spain) and Thorsten STEINER (276 Germany).
Edition EUROPEAN STROKE JOURNAL, LONDON, SAGE PUBLICATIONS LTD, 2019, 2396-9873.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30210 Clinical neurology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14110/19:00112987
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1177/2396987319863606
UT WoS 000485057700001
Keywords in English Stroke; thrombolysis; thrombectomy; oral anticoagulation; patent foramen ovale; prehospital; intracerebral haemorrhage; ischaemic stroke
Tags 14110127, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 18/2/2020 11:55.
Abstract
The purpose of the European Stroke Organisation-Karolinska Stroke Update Conference is to provide updates on recent stroke therapy research and to give an opportunity for the participants to discuss how these results may be implemented into clinical routine. The meeting started 22 years ago as Karolinska Stroke Update, but since 2014 it is a joint conference with European Stroke Organisation. Importantly, it provides a platform for discussion on the European Stroke Organisation guidelines process and on recommendations to the European Stroke Organisation guidelines committee on specific topics. By this, it adds a direct influence from stroke professionals otherwise not involved in committees and work groups on the guideline procedure. The discussions at the conference may also inspire new guidelines when motivated. The topics raised at the meeting are selected by the scientific programme committee mainly based on recent important scientific publications. This year's European Stroke Organisation-Karolinska Stroke Update Meeting was held in Stockholm on 11-13 November 2018. There were 11 scientific sessions discussed in the meeting including two short sessions. Each session except the short sessions produced a consensus statement (Full version with background, issues, conclusions and references are published as web-material and at and ) and recommendations which were prepared by a writing committee consisting of session chair(s), scientific secretary and speakers. These statements were presented to the 250 participants of the meeting. In the open meeting, general participants commented on the consensus statement and recommendations and the final document were adjusted based on the discussion from the general participants Recommendations (grade of evidence) were graded according to the 1998 Karolinska Stroke Update meeting with regard to the strength of evidence. Grade A Evidence: Strong support from randomised controlled trials and statistical reviews (at least one randomised controlled trial plus one statistical review). Grade B Evidence: Support from randomised controlled trials and statistical reviews (one randomised controlled trial or one statistical review). Grade C Evidence: No reasonable support from randomised controlled trials, recommendations based on small randomised and/or non-randomised controlled trials evidence.
PrintDisplayed: 26/4/2024 03:26